SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language

CARDIOVASCULAR

International | eng
Country Language

HeartMate 3 LVAD

With Full Maglev Flow Technology

About HeartMate 3

About HeartMate 3 LVAD with Full MagLev Flow Technology

The HeartMate 3™ LVAD with Full MagLev™ Flow Technology has significantly advanced the field of LVAD therapy, setting the standard with innovation and outstanding clinical outcomes that make a meaningful difference in your patients’ lives.1

Full MagLev Flow Technology maintains gentle blood handling to minimize complications and hemocompatibility-related adverse events.1

The HeartMate 3 LVAD is used for advanced heart failure patients needing short- or long-term mechanical circulatory support.

Outcomes made possible by Full MagLev Flow Technology

Full MagLev Flow Technology maintains gentle blood handling to minimize complications and hemocompatibility-related adverse events.

  • Fully levitated, self-centering rotor that does not require hydrodynamic or mechanical bearings
  • Large, consistent blood flow pathways to reduce shear stress3
  • Intrinsic pulsatility to reduce stasis and minimize thrombus3,4
Cut across view of the HeartMate 3 Maglev Pump

Why the HeartMate 3 LVAD

Time may run out for patients put on the waiting list, to receive a heart transplantation. Their condition may require earlier intervention than a donor heart would become available. Some of these patients may benefit from a left ventricular assist device (LVAD), an implanted heart pump which can help the heart pump oxygen-rich blood throughout the body and potentially improve the symptoms of advanced heart failure.1

An LVAD is designed to restore blood flow and improve survival outcome, functional status, and quality of life in patients while minimizing complications such as stroke and thrombosis. Intended for a broad range of advanced heart failure patients, LVADs are an option for patients with NYHA Class IIIB or IV heart failure and can be used for both short-term and long-term heart support including:

  • Bridge to transplantation: short term (ST) indication (for people waiting for a donor heart)
  • Destination therapy: long term (LT) indication also called permanent support (for people who are ineligible for heart transplantation)


Advanced Heart Failure Treatment for Better Quality of Life

You may find it reassuring to know that there are thousands of people around the world with LVADs living active, productive lives. They are spending time with friends and family and doing the things they love.5

HeartMate 3 LVADs set the standard in heart failure LVAD therapy through innovation, experience and outstanding outcomes.1 Our goal, like yours, is to keep patients with heart failure moving forward with the best possible quality of life.

Manuals & Resources

Manuals & Resources

Customer Service

Customer Service

This device is commercially available for use in select international markets.

References

  1. Mehra M, Uriel N, Naka Y, et al. A Fully Magnetically Levitated Left Ventricular Assist Device-Final Report. N Engl J Med. 2019;380:1618-1627.
  2. Abbott data on file.
  3. Bourque K, Cotter C, Dague C, et al. Design rationale and preclinical evaluation of the HeartMate 3 Left Ventricular Assist System for hemocompatibility. Am Soc Artificial Int Organs. 2016;62:375- 383.
  4. Bourque K, Dague C, Farrar D, et al. In vivo assessment of a rotary left ventricular assist device induced artificial pulse in the proximal and distal aorta. Artificial Organs. 2006;30:638-642.
  5. Abbott Data on File as of March 2021.

MAT-2105166 v4.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2025 Abbott. All Rights Reserved.

MAT-2001111 v8.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

YES

MAT-2305078 v1.0